Mortality and Revascularization Among Myocardial Infarction Patients with Schizophrenia: A Population-Based Cohort Study

Overview

Journal Can J Psychiatry

Specialty Psychiatry

Date 2020 Feb 5

PMID 32013569

Citations 8

Authors

Tanya S Hauck

Ning Liu

Harindra C Wijeysundera

Paul Kurdyak

Affiliations

Soon will be listed here.

Abstract

Background: Cardiovascular disease is a major source of mortality in schizophrenia, and access to care after acute myocardial infarction (AMI) is poor for these patients.

Aims: To understand the relationship between schizophrenia and access to coronary revascularization and the impact of revascularization on mortality among individuals with schizophrenia and AMI.

Method: This study used a retrospective cohort of AMI in Ontario between 2008 and 2015. The exposure was a diagnosis of schizophrenia, and patients were followed 1 year after AMI discharge. The primary outcome was all-cause mortality within 1 year. Secondary outcomes were cardiac catheterization and revascularization (percutaneous coronary intervention or coronary artery bypass graft). Cox proportional hazard regression models were used to study the relationship between schizophrenia and mortality, and the time-varying effect of revascularization.

Results: A total of 108,610 cases of incident AMI were identified, among whom 1,145 (1.1%) had schizophrenia. Schizophrenia patients had increased mortality, with a hazard ratio (HR) of 1.55 (95% CI, 1.37 to 1.77) when adjusted for age, sex, income, rurality, geographic region, and comorbidity. After adjusting for time-varying revascularization, the HR reduced to 1.38 (95% CI, 1.20 to 1.58). The impact of revascularization on mortality was similar among those with and without schizophrenia (HR: 0.42; 95% CI, 0.41 to 0.44 vs. HR: 0.40; 95% CI, 0.26 to 0.61).

Conclusions: In this sample of AMI, mortality in schizophrenia is increased, and treatment with revascularization reduces the HR of schizophrenia. The higher mortality rate yet similar survival benefit of revascularization among individuals with schizophrenia relative to those without suggests that increasing access to revascularization may reduce the elevated mortality observed in individuals with schizophrenia.

Citing Articles

Cardiovascular comorbidities in Chinese inpatients with schizophrenia spectrum disorders.

Dong Z, Wu G, Liu H, Chen S, Bi B, Zhang F Schizophrenia (Heidelb). 2025; 11(1):22.

PMID: 39971916 PMC: 11840127. DOI: 10.1038/s41537-025-00576-3.

In-hospital mortality and cardiovascular treatment during hospitalization for heart failure among patients with schizophrenia: a nationwide cohort study.

Nishi M, Shikuma A, Seki T, Horiguchi G, Matoba S Epidemiol Psychiatr Sci. 2023; 32:e62.

PMID: 37849318 PMC: 10594642. DOI: 10.1017/S2045796023000744.

Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Severe Mental Illness: A Systematic Review and Meta-analysis.

Chan J, Chu R, Hung C, Law J, Wong C, Chang W Schizophr Bull. 2022; 48(5):981-998.

PMID: 35786737 PMC: 9434477. DOI: 10.1093/schbul/sbac070.

Interaction Between Race, Ethnicity, Severe Mental Illness, and Cardiovascular Disease.

OGallagher K, Teo J, Shah A, Gaughran F J Am Heart Assoc. 2022; 11(12):e025621.

PMID: 35699192 PMC: 9238657. DOI: 10.1161/JAHA.121.025621.

Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors.

Correll C, Solmi M, Croatto G, Schneider L, Rohani-Montez S, Fairley L World Psychiatry. 2022; 21(2):248-271.

PMID: 35524619 PMC: 9077617. DOI: 10.1002/wps.20994.

References

Rosenbaum L . Closing the Mortality Gap - Mental Illness and Medical Care. N Engl J Med. 2016; 375(16):1585-1589. DOI: 10.1056/NEJMms1610125. View

Jakobsen L, Terkelsen C, Christiansen E, Maeng M, Jensen L, Veien K . Severe Mental Illness and Clinical Outcome After Primary Percutaneous Coronary Intervention. Am J Cardiol. 2017; 120(4):550-555. DOI: 10.1016/j.amjcard.2017.05.021. View

Kurdyak P, Vigod S, Calzavara A, Wodchis W . High mortality and low access to care following incident acute myocardial infarction in individuals with schizophrenia. Schizophr Res. 2012; 142(1-3):52-7. DOI: 10.1016/j.schres.2012.09.003. View

Enger C, Weatherby L, Reynolds R, Glasser D, Walker A . Serious cardiovascular events and mortality among patients with schizophrenia. J Nerv Ment Dis. 2004; 192(1):19-27. DOI: 10.1097/01.nmd.0000105996.62105.07. View

Ko D, Wijeysundera H, Jackevicius C, Yousef A, Wang J, Tu J . Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins. Circ Cardiovasc Qual Outcomes. 2013; 6(3):315-22. DOI: 10.1161/CIRCOUTCOMES.111.000015. View

Nielsen J, Juel J, Alzuhairi K, Al Zuhairi K, Friis R, Graff C . Unrecognised myocardial infarction in patients with schizophrenia. Acta Neuropsychiatr. 2015; 27(2):106-12. DOI: 10.1017/neu.2014.41. View

Schulman-Marcus J, Goyal P, Swaminathan R, Feldman D, Wong S, Singh H . Comparison of Trends in Incidence, Revascularization, and In-Hospital Mortality in ST-Elevation Myocardial Infarction in Patients With Versus Without Severe Mental Illness. Am J Cardiol. 2016; 117(9):1405-10. DOI: 10.1016/j.amjcard.2016.02.006. View

Schultz S, Rothwell D, Chen Z, Tu K . Identifying cases of congestive heart failure from administrative data: a validation study using primary care patient records. Chronic Dis Inj Can. 2013; 33(3):160-6. View

Tu K, Campbell N, Chen Z, Cauch-Dudek K, McAlister F . Accuracy of administrative databases in identifying patients with hypertension. Open Med. 2010; 1(1):e18-26. PMC: 2801913. View

10.

Laursen T, Munk-Olsen T, Agerbo E, Gasse C, Mortensen P . Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry. 2009; 66(7):713-20. DOI: 10.1001/archgenpsychiatry.2009.61. View

11.

Wu S, Chen S, Juang J, Fang C, Liu S, Sun F . Diagnostic procedures, revascularization, and inpatient mortality after acute myocardial infarction in patients with schizophrenia and bipolar disorder. Psychosom Med. 2012; 75(1):52-9. DOI: 10.1097/PSY.0b013e31827612a6. View

12.

Mitchell A, Lord O . Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis. J Psychopharmacol. 2010; 24(4 Suppl):69-80. PMC: 2951596. DOI: 10.1177/1359786810382056. View

13.

Kurdyak P, Lin E, Green D, Vigod S . Validation of a Population-Based Algorithm to Detect Chronic Psychotic Illness. Can J Psychiatry. 2015; 60(8):362-8. PMC: 4542516. DOI: 10.1177/070674371506000805. View

14.

Druss B, Bradford D, Rosenheck R, Radford M, Krumholz H . Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA. 2000; 283(4):506-11. DOI: 10.1001/jama.283.4.506. View

15.

Kisely S, Campbell L, Wang Y . Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare. Br J Psychiatry. 2009; 195(6):545-50. DOI: 10.1192/bjp.bp.109.067082. View

16.

Callaghan R, Boire M, Lazo R, McKenzie K, Cohn T . Schizophrenia and the incidence of cardiovascular morbidity: a population-based longitudinal study in Ontario, Canada. Schizophr Res. 2009; 115(2-3):325-32. DOI: 10.1016/j.schres.2009.07.018. View

17.

Cox J, Melady M, Chen E, Naylor C . Towards improved coding of acute myocardial infarction in hospital discharge abstracts: a pilot project. Can J Cardiol. 1997; 13(4):351-8. View

18.

Ko D, Austin P, Chan B, Tu J . Quality of care of international and Canadian medical graduates in acute myocardial infarction. Arch Intern Med. 2005; 165(4):458-63. DOI: 10.1001/archinte.165.4.458. View

19.

Tu J, Naylor C, Austin P . Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996. CMAJ. 1999; 161(10):1257-61. PMC: 1230787. View

20.

Casey D, Haupt D, Newcomer J, Henderson D, Sernyak M, Davidson M . Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry. 2004; 65 Suppl 7:4-18. View